These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28317526)

  • 1. Medical and Maintenance Treatments for Vitiligo.
    Passeron T
    Dermatol Clin; 2017 Apr; 35(2):163-170. PubMed ID: 28317526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo: an update on systemic treatments.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic treatment of vitiligo : Balance and current developments].
    Meurer M; Ceric-Dehdari P
    Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo treatment update.
    Daniel BS; Wittal R
    Australas J Dermatol; 2015 May; 56(2):85-92. PubMed ID: 25495880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.
    Kim SR; Heaton H; Liu LY; King BA
    JAMA Dermatol; 2018 Mar; 154(3):370-371. PubMed ID: 29387870
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical cream delivers NB-UVB from sunlight for the treatment of vitiligo.
    Wang X; McCoy J; Lotti T; Goren A
    Expert Opin Pharmacother; 2014 Dec; 15(18):2623-7. PubMed ID: 25363734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
    J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Advanced Therapeutic Approaches to Treat Vitiligo.
    Sharma CK; Sharma M; Aggarwal B; Sharma V
    J Environ Pathol Toxicol Oncol; 2015; 34(4):321-34. PubMed ID: 26756425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home phototherapy in vitiligo.
    Mohammad TF; Silpa-Archa N; Griffith JL; Lim HW; Hamzavi IH
    Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):241-252. PubMed ID: 28620923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration.
    Park JH; Park SW; Lee DY; Lee JH; Yang JM
    Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):103-5. PubMed ID: 23458396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
    Ju HJ; Bae JM
    Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototherapy for vitiligo, what's new?
    Paro Vidolin A; Aurizi C; Leone G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phototherapy: The vitiligo management pillar.
    Esmat S; Mostafa W; Hegazy RA; Shalaby S; Sheth V; Youssef R; El-Mofty M
    Clin Dermatol; 2016; 34(5):594-602. PubMed ID: 27638438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
    McKesey J; Pandya AG
    J Am Acad Dermatol; 2019 Aug; 81(2):646-648. PubMed ID: 31009664
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
    Taieb A; Alomar A; Böhm M; Dell'anna ML; De Pase A; Eleftheriadou V; Ezzedine K; Gauthier Y; Gawkrodger DJ; Jouary T; Leone G; Moretti S; Nieuweboer-Krobotova L; Olsson MJ; Parsad D; Passeron T; Tanew A; van der Veen W; van Geel N; Whitton M; Wolkerstorfer A; Picardo M; ; ;
    Br J Dermatol; 2013 Jan; 168(1):5-19. PubMed ID: 22860621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment and combination approaches for vitiligo: new insights, new developments.
    Hossani-Madani AR; Halder RM
    G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.